Third Rock Ventures IV L.P. 13D and 13G filings for Magenta Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:53 pm Purchase | 2021-12-31 | 13G | Magenta Therapeutics, Inc. MGTA | Third Rock Ventures IV L.P. | 6,758,204 11.500% | 6,758,204 (New Position) | Filing |